Nonoperative management in low-lying rectal cancers undergoing chemoradiation
Indian Journal of Cancer · 2025
DOI: 10.4103/ijc.ijc_1248_21 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Cancer, 2025. Verfasst von Debanjali Datta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Rectal Neoplasms, Chemoradiotherapy. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
To evaluate outcomes of postneoadjuvant chemoradiotherapy (NACTRT) wait and watch strategy (WWS) in distal rectal cancers.
Methods
All consecutive patients from December 2012 to 2019 diagnosed with distal rectal tumors (T2-T4 N0-N+) having a complete or near-complete response (cCR or nCR respectively) post-NACTRT and wished for nonsurgical treatment option of WWS were included in this study. Patients were observed with 3 monthly MRI, sigmoidoscopy, and digital rectal examination (DRE) for 2 years and 6 monthly thereafter. Organ preservation rate (OPR), local regrowth rate (LRR), nonregrowth recurrence-free survival, and overall survival (OS) were estimated using the Kaplan–Meier method, and factors associated with LRR were identified on univariate and multivariate analysis using the log-rank test ( P < 0.05 significant).
Results
Sixty-one consecutive patients post-NACTRT, achieving cCR [44 (72%)] and nCR [17 (28%)], respectively, were identified. All patients received pelvic radiotherapy to a dose of 45–50Gy conventional fractionation with concurrent Capecitabine. Additional boost dose with either external beam or brachytherapy was given to 39 patients. At a median follow-up of 39 months, 11 (18%) patients had local regrowth, of which seven were salvaged with surgery and the rest are alive with disease, as they refused surgery. The overall OPR, nonregrowth recurrence-free survival, OS was 83%, 95%, and 98%, respectively. Seven (11%) patients developed distant metastasis, of which six underwent metastasectomy and are alive and well. LRR was higher in patients with nCR versus cCR ( P = 0.05).
Conclusion
The wait-and-watch strategy is a safe nonoperative alternative management for selected patients attaining cCR/nCR after NACTRT with excellent outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
- Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
- Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
- Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
- Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Zitieren
APA
Datta, D., Engineer, R., Saklani, A., D'souza, A., Baheti, A., Kumar, S., Krishnatry, R., Ostwal, V., Ramaswamy, A., & Patil, P. (2025). Nonoperative management in low-lying rectal cancers undergoing chemoradiation. Indian Journal of Cancer. https://doi.org/10.4103/ijc.ijc_1248_21
Vancouver
Datta D, Engineer R, Saklani A, D'souza A, Baheti A, Kumar S, et al. Nonoperative management in low-lying rectal cancers undergoing chemoradiation. Indian Journal of Cancer. 2025. doi:10.4103/ijc.ijc_1248_21
BibTeX
@article{Datta2025,
author = {Datta, Debanjali and Engineer, Reena and Saklani, Avanish and D'souza, Ashwin and Baheti, Akshay and Kumar, Suman and Krishnatry, Rahul and Ostwal, Vikas and Ramaswamy, Anant and Patil, Prachi},
title = {Nonoperative management in low-lying rectal cancers undergoing chemoradiation},
journal = {Indian Journal of Cancer},
year = {2025},
doi = {10.4103/ijc.ijc_1248_21}
}
EUVIMED